STOCK TITAN

PTNTD Financials

PTNTD
FY2025 annual
Revenue $0 -100.0% YoY
Net Income Not reported for FY2025
EPS (Diluted) -$32.15 YoY not available
Free Cash Flow Not reported for FY2025
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Mar 31, 2026 Reported Currency USD FYE June

Newest figures come from the 10-K for Q3 FY2026, filed May 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PTNTD SEC filings page.

PTNTD (PTNTD) reported $0 in revenue for fiscal year 2025, down 100.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PTNTD FY2025

Development-stage economics dominate: research spending remains far above revenue, losses consume cash, and financing—not operations—supports the balance sheet.

From FY2023 to FY2024, revenue fell 7.5% while operating loss narrowed 30.7% as SG&A declined and R&D stayed nearly level, pointing to cost reallocation rather than commercial scale. In FY2024, operating cash flow was -$31.5M against a net loss of -$29.7M, so accounting losses were closely mirrored by cash use rather than dominated by non-cash charges.

R&D reached $22.4M against $4.5M of FY2024 revenue, making development expense the central operating commitment; SG&A was lower than the prior year, but that reduction did not bring the business near break-even.

By FY2024, liabilities slightly exceeded assets and equity was negative, while the current ratio was 1.0x; accumulated losses therefore left little short-term balance-sheet cushion. The operating cash need was offset by $20.5M of financing inflows and $12.5M of investing inflows, indicating reliance on non-operating funding sources.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

PTNTD does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$3.9M
QoQ+3278.8%

PTNTD generated $3.9M in revenue in Q3 2026. Against the prior quarter it is up 3278.8%.

EBITDA
-$1.6M
YoY+67.1%
QoQ+78.6%

PTNTD's EBITDA was -$1.6M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 67.1% from the same quarter a year earlier. Against the prior quarter it is up 78.6%.

Net Income
-$1.4M
YoY+70.2%
QoQ+80.3%

PTNTD reported -$1.4M in net income in Q3 2026. This represents an increase of 70.2% from the same quarter a year earlier. Against the prior quarter it is up 80.3%.

EPS (Diluted)
-$0.37

PTNTD earned -$0.37 per diluted share (EPS) in Q3 2026.

Cash & Balance Sheet

Free Cash Flow
-$4.5M
YoY+16.8%

PTNTD recorded an outflow of $4.5M in free cash flow in Q3 2026, representing a cash shortfall after capex. This represents an increase of 16.8% from the same quarter a year earlier.

Cash & Debt
$10.2M
YoY+303.1%
QoQ-29.8%

PTNTD held $10.2M in cash as of Q3 2026; long-term debt is not reported for that period.

Shares Outstanding
2M
5Y CAGR-62.2%
10Y CAGR-30.5%

PTNTD had 2M shares outstanding in Q3 2026.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Operating Margin
-40.3%

PTNTD's operating margin was -40.3% in Q3 2026, reflecting core business profitability.

Net Margin
-36.5%

PTNTD's net profit margin was -36.5% in Q3 2026, showing the share of revenue converted to profit.

Return on Equity
-13.5%
QoQ+49.8pp

PTNTD's ROE was -13.5% in Q3 2026, measuring profit generated per dollar of shareholder equity. Against the prior quarter it is up 49.8 percentage points.

Gross Margin

Not reported for Q3 2026.

Capital Allocation

R&D Spending
$3.5M
YoY-6.3%
QoQ-18.6%

PTNTD invested $3.5M in research and development in Q3 2026. This represents a decrease of 6.3% from the same quarter a year earlier. Against the prior quarter it is down 18.6%.

Capital Expenditures
$38K

PTNTD invested $38K in capex in Q3 2026, funding long-term assets and infrastructure.

Share Buybacks

Not reported for Q3 2026.

PTNTD Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PTNTD quarterly income statement
MetricQ3'2610-KQ2'2610-QQ1'2610-KQ4'2510-KQ3'25Q2'2510-QQ1'25Q4'2410-K
Revenue$3.9M$116K$8.8MN/A$0N/A$0-100.0%N/A
R&D Expenses$3.5M-6.3%$4.3M+26.0%$2.5M-56.0%N/A$3.8M-47.6%$3.4M-38.3%$5.7M+14.5%N/A
SG&A Expenses$2.0M+34.6%$3.1M+85.8%$1.7M-17.8%N/A$1.5M-27.5%$1.7M-44.5%$2.0M-36.9%N/A
Operating Income-$1.6M+67.2%-$7.3M-180.6%$4.7M+160.0%N/A-$4.8M+47.8%-$2.6M-322.6%-$7.8M-27.1%N/A
EBITDA-$1.6M+67.1%-$7.3M-188.0%$4.7M+160.8%N/A-$4.8M-$2.5M-$7.7M-27.6%N/A
Interest Expense$1K-29.4%$498-86.9%$2K-66.3%N/A$2K+43.1%$4K+136.9%$6K-45.4%N/A
Net Income-$1.4M+70.2%-$7.3M-197.4%$4.7M+159.8%N/A-$4.8M+43.0%-$2.4M+68.9%-$7.8M-50.3%N/A
EPS (Basic)-$0.37+95.9%-$2.86+51.7%$4.81+124.4%N/A-$9.13-$5.92-957.1%-$19.71-4483.7%N/A
EPS (Diluted)-$0.37-$2.86$4.26N/A-$9.13-$5.92-$19.71N/A
Diluted Shares (Avg)4M3M1MN/A526,891412,697396,909N/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, Income Tax.

PTNTD Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PTNTD quarterly balance sheet
MetricQ3'2610-KQ2'2610-QQ1'2610-KQ4'2510-KQ3'25Q2'2510-QQ1'25Q4'2410-K
Total Assets$13.2M+254.7%$17.9M+316.0%$8.6M+152.2%$3.3M-69.6%$3.7M-67.3%$4.3M-68.2%$3.4M-69.6%$10.7M-40.1%
Current Assets$12.8M+295.4%$17.5M+376.0%$8.4M+220.4%$2.9M-70.1%$3.2M-68.5%$3.7M-70.0%$2.6M-73.4%$9.8M-40.1%
Cash & Equivalents$10.2M+303.1%$14.5M+323.7%$1.3M-46.6%$2.6M-73.1%$2.5M$3.4M-64.0%$2.4M-56.8%$9.5M-13.2%
InventoryN/AN/AN/AN/AN/AN/AN/A$0-100.0%
Accounts ReceivableN/A$1.6M$6.9M$0N/AN/AN/A$0-100.0%
Total Liabilities$2.6M-74.0%$6.5M-39.6%$8.2M-26.0%$8.0M-25.9%$10.1M+2.9%$10.7M-56.4%$11.1M-31.2%$10.9M-44.8%
Current Liabilities$2.5M-74.8%$6.3M-33.8%$8.2M-16.7%$8.0M-17.1%$10.0M+17.8%$9.6M-14.6%$9.9M-27.5%$9.7M-36.2%
Non-Current Liabilities$97K+44.9%$129K-88.6%$0-100.0%$34K-97.2%$67K-94.8%$1.1M-91.5%$1.2M-51.0%$1.2M-73.6%
Total Equity$10.6M+265.8%$11.5M+279.7%$396K+105.2%-$4.8M-4184.5%-$6.4M-504.5%-$6.4M+43.9%-$7.7M-21.6%-$111K+94.4%
Retained Earnings-$463.1M-1.4%-$461.7M-2.1%-$454.4M-1.1%-$459.1M-3.9%-$456.8M-5.4%-$452.0M-6.3%-$449.6M-6.7%-$441.8M-7.2%

Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments, Goodwill, Long-Term Debt.

PTNTD Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PTNTD quarterly cash flow statement
MetricQ3'2610-KQ2'2610-QQ1'2610-KQ4'2510-KQ3'25Q2'2510-QQ1'25Q4'2410-K
Operating Cash Flow-$4.4M+17.5%-$4.8M+0.8%-$1.6M+76.9%-$4.1M+36.8%-$5.4M+37.8%-$4.8M+53.7%-$7.0M-18.8%-$6.5M+32.6%
Depreciation & Amortization$17K-68.2%$14K-80.0%$14K-82.2%N/A$53K$72K$81K-7.5%N/A
Stock-Based CompensationN/AN/A$168K-51.9%N/AN/A$349K-36.6%$349K-10.6%N/A
Capital Expenditures$38KN/AN/A$0-100.0%$0N/AN/A$5K-90.6%
Free Cash Flow-$4.5M+16.8%N/AN/A-$4.1M+36.9%-$5.4M+37.8%N/AN/A-$6.5M+32.9%
Investing Cash Flow-$38KN/AN/A$630K+12928.3%$0$2.5M-73.6%$0-100.0%-$5K+99.8%
Financing Cash Flow$139K-96.9%$18.0M+433.3%$328K+358.5%$3.5M-41.5%$4.5M-51.2%$3.4M-32.1%-$127K-128.3%$6.0M+494.1%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

PTNTD Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PTNTD quarterly financial ratios
MetricQ3'2610-KQ2'2610-QQ1'2610-KQ4'2510-KQ3'25Q2'2510-QQ1'25Q4'2410-K
Operating Margin-40.3%-6315.8%52.8%N/AN/AN/AN/AN/A
Net Margin-36.5%-6260.0%53.0%N/AN/AN/AN/AN/A
Return on Equity-13.5%-63.3%1180.0%N/AN/AN/AN/AN/A
Return on Assets-10.8%+118.2pp-40.5%+16.1pp54.3%+283.4ppN/A-129.0%-55.1pp-56.7%+1.2pp-229.1%-182.8ppN/A
Current Ratio5.04+4.7x2.76+2.4x1.02+0.8x0.36-0.6x0.32-0.9x0.38-0.7x0.26-0.5x1.01-0.1x
Debt-to-Equity0.250.5620.73N/AN/AN/AN/AN/A
Asset Turnover0.30+0.3x0.011.02+1.0xN/A0.000.0xN/A0.00-0.2xN/A
FCF Margin-113.6%N/AN/AN/AN/AN/AN/AN/A

Not reported in any period shown, so not listed: Gross Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Note: Shareholder equity is negative (-$4.8M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.36), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

What is PTNTD's annual revenue?

PTNTD (PTNTD) reported $0 in total revenue for fiscal year 2025. This represents a -100.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is PTNTD's revenue growing?

PTNTD (PTNTD) revenue declined by 100.0% year-over-year, from $4.5M to $0 in fiscal year 2025.

What is PTNTD's earnings per share (EPS)?

PTNTD (PTNTD) reported diluted earnings per share of -$32.15 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

PTNTD (PTNTD) had $3.3M in total assets as of fiscal year 2025, including both current and long-term assets.

PTNTD (PTNTD) reported no capital expenditure during fiscal year 2025.

PTNTD (PTNTD) invested $14.9M in research and development during fiscal year 2025.

PTNTD (PTNTD) had 929,597 shares outstanding as of fiscal year 2025.

PTNTD (PTNTD) had a current ratio of 0.36 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

PTNTD (PTNTD) has negative shareholder equity of -$4.8M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Back to top